uroportal

Diagnostic Accuracy of Targeted Prostate Biopsies: A Prospective Trial Comparing MicroUltrasound with Multiparametric MRI for the Detection of Prostate Cancer
Single centre audit of implementation of a care pathway in penile cancer
Making a judgement on the potential curability of recurrent Renal Cell Carcinoma (RCC): Differences in global per protocol vs. investigator based assessment
The 4 years’ NMIBC recurrence rates within a prospective, randomized-controlled clinical setting – NBI versus standard TURBT diagnostic accuracy and long-term evidence-based oncologic outcome
Cabozantinib versus everolimus in patients with advanced renal cell carcinoma from Europe and the rest of the world: subgroup analysis of the METEOR trial
Automated Gleason grading of prostate cancer via deep learning
Laparoscopic (robot-assisted) VEIL video demonstration & single centre experience
Laparoscopic-assisted robotic retroperitoneal lymph node dissection (R-RPLND) for non seminomatous germ cell tumor of testis: Single centre initial experience
Post-chemotherapy residual mass resection in testicular cancer
Neutrophil to lymphocyte ratio: A recurrence predictor in testicular cancer
Clinical analysis of extragonadal germ cell tumors in our hospital
Hematolymphoid testicular tumors: a single-institution clinicopathological characterization of 32 cases
Diagnostic challenges of testicular sex cord – stromal tumors: A review of 29 cases from two cancer centers
The neutrophil to lymphocyte ratio role as a diagnostic tool in testicular cancer
Non-invasive detection of bladder cancer and its recurrence in exfoliated cells from urine sediment by assessing the presence of telomerase activity
The role of frozen section examination (FSE) during inguinal exploration in 1052 patients with inconclusive testicular lesions
Establishing a resource for comprehensive molecular subtyping of bladder cancer
Expression of the microRNAs miR-100, miR-138 y miR-let-7c in non-muscle invasive bladder cancer: clinicopathological significance and prognostic value
Safety and activity of sorafenib in addition to vinflunine in post-platinum metastatic urothelial carcinoma (Vinsor): Phase I trial
Health-related quality of life in non-muscle invasive bladder cancer patients: Comparison to a normative population and changes after diagnosis
Low awareness, adherence and practice but positive attitudes regarding lifestyle recommendations among bladder cancer patients
Urodynamic assessment of orthotopic neobladder reconstruction following radical cystectomy in bladder cancer
Lipid cell variant shows worst prognosis among the variants of urothelial carcinoma of the urinary bladder
Neutrophil-to-lymphocyte ratio predicts the 5-year recurrence of bladder cancer after transurethral resection of bladder tumor
Preoperative neutrophil – Limphocyte ratio as a progression and survival factor in patients with bladder cancer undergoing radical cystectomy
Pre-treatment lymphocytopenia predicts poor prognosis for patients with metastatic urothelial carcinoma treated with platinum-based first-line chemotherapy
Predictors for development 30-day complications after radical cystectomy (RC)
Sarcomatoid urothelial bladder cancer: Symptomatology, treatment and survival
Achieving “Trifecta” outcomes in robotic radical cystectomy for bladder cancer: Single surgeon-single institute prospective and retrospective analysis
Monopolar transurethral resection of bladder tumors preformed by a urology resident: Is it safe for the patient?
Complete urinary tract extirpation: Oncological outcome
Metastasectomy in oligometastatic urothelial cancer: oncological outcome
Modified ureterocutaneostomy after radical cystectomy in patients with bladder cancer
Practice pattern of non-muscle invasive bladder cancer in Japan, Taiwan and Korea: a web-based survey
Survival outcomes and salvage treatments for distant bladder cancer recurrence following radical cystectomy
Patterns of recurrence of bladder cancer following radical cystectomy
Adaptive radiotherapy for carcinoma of the urinary bladder: Long term outcomes with dose escalation
Pure endoscopic closure of bladder wall after transurethral disinsertion of distal ureter during laparoscopic nephroureterectomy: Proof of concept in humans
Partial nephrectomy in patients with high-risk upper tract urinary cancer
Effects of nonsteroidal anti- inflammatory drugs as patient controlled analgesia on early bowel function recovery after radical cystectomy
Could adjuvant chemotherapy have additional therapeutic benefit in muscle invasive bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy?
Does neoadjuvant chemotherapy affect postoperative complication rates in elderly patients treated with radical cystectomy for bladder cancer?
Radical radiotherapy in elderly patients with muscle invasive bladder cancer
The effect of second-line intravenous chemotherapy for advanced or metastatic urothelial carcinoma
Open vs laparoscopic radical cystectomy: Comparison of perioperative outcomes and complications in a single-center study
The first experience of using vacuum assisted closure in the treatment of complications after radical cystectomy
Expression of Her2-neu, SKP2 and HIF-1 and their role in predicting the response of muscle invasive urothelial carcinoma to bladder- preservation chemotherapy
Safe transition from extracorporeal to intracorporeal urinary diversion following robot- assisted cystectomy: A recipe for reducing operative time, blood loss and complication rates
Biopsy at flexible cystoscopy: Are we wasting our time?
Staging of pelvic lymph nodes in urothelial carcinoma of urinary bladder by 18-FDG PET CT and diffusion weighted MRI of pelvis: A prospective comparative study
Protective effect of pioglitazon against kidney ischemia-reperfusion
Increased activation of mammalian target of rapamycin pathway in renal cell carcinoma arising in native kidneys of dialyzed patients
Association of HLA-A, -B and -DRB1 genes with endemic nephropathy and urothelial carcinoma of upper urinary tract in Croatia
Efficacy and safety of pazopanib in patients with advanced and/or metastatic renal cell carcinoma (mRCC) after previous checkpoint inhibitor treatment
Transcriptomic profiling of VHL-dependent long noncoding RNAs in clear cell renal cell carcinoma
Self Reported Quality of Life Can Predict Overall Survival in Metastatic Renal Cell Carcinoma
Targeting bacteroides in the stool microbiome and response to treatment (Rx) with first- line VEGFTKI in metastatic renal cell carcinoma
Long-Terms Results of Nephron-Sparing Surgery in Centrally Located Tumors
A lower psoas muscle volume correlates with a higher recurrence rate in male clear cell renal cell carcinoma patients
Overall and progression free survival time in mRCC patients – Clinicopathological risk group analysis
Evaluating Pentafecta outcomes in robotic partial nephrectomy for T1b renal masses: Single institute-single surgeon retrospective analysis
Does sunitinib-induced hypothyroidism correlate with better outcomes in metastatic renal cell carcinoma?
VEGF tyrosine kinase inhibitors after bevacizumab and atezolizumab in metastatic clear cell renal cancer
Patient selection for cytoreductive nephrectomy: Predicting factors for complications and oncological survival
Efficacy and toxicity of targeted therapies in patients with metastatic renal cell carcinoma with renal insufficiency
A cost-effectiveness analysis of Nivolumab and Ipilimumab versus Sunitinib in first line intermediate-poor risk advanced Renal Cell Carcinoma
Cytoreductive nephrectomy with tumour thrombectomy (CNT) in renal cell carcinoma (RCC) patients with pulmonary metastases
The use of neoadjuvant targeted therapy in patients with localized renal-cell carcinoma
Multifactorial assessment of parameters affecting selection of appropriate surgical tactics in the treatment of localized renal cell carcinoma
Long-term functional results of partial nephrectomy in patients with tumors of solitary kidney
Complications of partial nephrectomy in patients with tumors of solitary functioning kidney
A retrospective study of the effect of metastasectomy on prognostic survival according to the metastatic organs in patients with metastatic renal cell carcinoma
Comparison of short-term renal function change according to renal hilar-clamp and width of safety margin after laparoscopic partial nephrectomy
Initial experience of early unclamping and delay clamping techniques of laparoscopic partial nephrectomy: Can these reduce warm ischemic time?
Dynamics of markers of acute kidney injury in renal cell carcinoma patients after laparoscopic partial nephrectomy under warm ischemia of the kidney
The role of renal biopsy in diagnosing and guiding management of suspected renal malignancy
Renal cell carcinoma with venous thrombus in metastatic patients at diagnosis, should surgery be offered?
Comparative analysis of indexes of renal function in terms of carbon dioxide pneumoperitoneum, gas-free & low-gas laparoscopy
Retroperitoneal versus transperitoneal laparoscopic partial nephrectomy: A comparison of perioperative and early oncological outcomes
MRI for assessment of inferior vena cava wall invasion by renal cell carcinoma with vena cava thrombi
Poor fat renal angiomiolipomes: image findings
Accurate risk assessment of patients with pathologic T3aN0M0 renal cell carcinoma
Comparison of Fuhrman nuclear grading system with a novel tumour grading system for chromophobe renal cell carcinoma and its correlation with clinical outcome
High prostate cancer detection rates on transperineal template biopsies of prostate using modified sector method and comparing the results with pre biopsy MRI. A result of first 100 cases
Matching the Gleason score of the prostate biopsy with the final pathological outcome: Our experience
Pathological changes in patients with prostate cancer undergoing active surveillance in a long-term follow-up
Incidence of Extraprostatic Extension in Grade Group 1 Prostate Cancers Treated With Radical Prostatectomy: Should These Lesions Cease To Be Considered As Cancers?
Isolation and characterization of urine exosomes for using as diagnostic biomarkers in Prostate Cancer
Identifying patients with metastatic Castration-Resistant Prostate Cancers (mCRPC) in the SNDS database: CAMERRA study
Isolation of prostate cancer-specific circulating tumor cells for androgen receptor splice variant 7 analysis: The AdnaTest ProstateCancer versus the Gilupi CellCollector
mi RNA 182 and 187 as potential biomarker in prostate cancer patients and its correlation with staging of prostate cancer
Study of TMPRSS2-ETS molecular translocations in prostate cancer by fluorescence in-situ hybridization and real time polymerase chain reaction and its correlation with clinical and biochemical parameters
Multicenter registry of CRPC patients: Clinical characteristics and natural history of the disease
Predicting bone metastasis on pretreatment imaging in men with intermediate or high risk prostate cancer: A nationwide, population-based study
Nonoperative management of acquired rectourethral fistula: The modern approach
Routine use of Prostate Health Index (PHI) reduces majority of unnecessary prostatic biopsies in Asian men: A prospective study in 2795 men seen at Urology clinics
Lower Urinary Tract Symptoms (LUTS) not associated to increased risk of prostate cancer
Investigation of noninvasive urine specimens with molecular profile fluctuations for a presence of high-risk human papilloma viruses as an inflammatory cofactor in the complicated origin of prostate cancer
Microsatellite AR and VDR markers as genetic risk factors in association with Prostate cancer and aggressive profile
Novel genetic marker to define high Gleason score from GWAS to basic research
Large cribriform growth in Gleason 3+4=7 prostate cancer
Enzalutamide with or without prior anti-androgen treatment for castration resistant prostate cancer (CRPC): Results from the Dutch CAPRI registry
Volatile organic compounds as possible biomarker for prostate cancer detectión. Results of a pilot study
The potentials of AR, AR-regulated TMPRSS2-ERG fusion and KLK3 mRNAs for prostate cancer risk assessment in suspicious prostate biopsy cores with atypical small acinar proliferation
Polymorphisms of 5’-utr of rad51 gene in prostate cancer
Upgrading in familial prostate cancer
Impact of Gonadotropin-releasing Hormone Agonist on Cardiovascular Disease and Diabetes Mellitus in Prostate Cancer Patients: A Nationwide Population-based Cohort Study
Antialgic radiotherapy in castration resisten prostate cancer. A university hospital experience
Exercise prescription dose for castration resistant prostate cancer patients: A phase I prescription dose escalation trial
Prostate volume reduction in patients treated with Abiraterone and Enzalutamide: The forgotten outcome in Clinical trials
The association of a number of risk factors with depression in patients with prostate cancer undergoing androgen deprivation therapy
Prognostic impact of end of radiotherapy PSA (EORT-PSA) on long-term outcomes in patients with cN1 prostate cancer (PC)
Prevalence of a polymorphic variant of HSD3B1 in benign and malignant prostate diseases and its prognostic value in castration-resistant prostate cancer
2-weekly vs 3-weekly docetaxel in CRPC: A retrospective, single-institute study
Survival impact of the management of medical and urological complications during treatment with 1st line abiraterone (A) or enzalutamide (E) in patients with metastatic castration-resistant prostate cancer (mCRPC)
Long-term functional and oncological outcomes of salvage cryosurgery for recurrent prostate cancer: A 12-year experience single-center analysis
A single-center experience with abiraterone acetate in metastatic castration resistant prostate cancer
Enzalutamide in metastatic castration resistant prostate cancer, a single center experience
Impact of 18F-DCFPyL PSMA PET scanning in patients undergoing post prostatectomy radiotherapy (IMPPORT) – a multi-site prospective trial
Incidence of urological complications in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first line abiraterone and enzalutamide
Should we involve patients more actively? Perspectives of the multidisciplinary team on shared decision-making for metastatic castration-resistant prostate cancer
Potential prognostic factors for metastatic castration resistant prostate cancer with Abiraterone Acetate
Abiraterone acetate vs. Enzalutamide for metastatic castration-resistant prostate cancer
Efficacy of Abiraterone acetate plus Prednisone and Enzalutamide sequences in men with metastatic castration-resistant prostate cancer: Systematic review and meta-analysis
Post-docetaxel survival in metastatic castration-resistant prostate cancer (mCRPC) is improving in the Netherlands
The efficacy of stereotactic body radiation therapy and the impact of systemic treatments in oligometastatic patients from prostate cancer
Comparing stereotactic body radiotherapy and elective nodal radiotherapy in the management of nodal oligorecurrent prostate cancer: a multi-institutional analysis
Impact of metastasis status on abireteron outcomes in patients with metastatic castration resistant prostate cancer
Assessment of association between clinical characteristics and prostate specific antigen (PSA) progression in men with prostate cancer (PCa) receiving a leuprorelin acetate implant: Results from the non-interventional German cohort LEAN study
Data of efficacy and toxicity for Radium-223 in patients with metastatic castration- resistant prostate cancer in real-life setting: A single-center experience
Castration-Resistant Metastatic Prostate Carcinoma (CPRCm)
Effect of PectaSol-C modified citrus pectin (P-MCP) treatment (tx) on PSA Dynamics in non- metastatic Biochemically Relapsed Prostate Cancer (BRPC) patients (pts): Results of a prospective Phase II Study
Correlation between the location of the index tumour and the location of positive lymph nodes in high-risk prostate cancer. A monocentric positive lymph node mapping study
Integrated assessment and correction of osteoporosis in patients with prostate cancer on the background of drug and surgical castration
Neuroendocrine tissue markers in castration-resistant prostate cancer
Conformance of PI-RADS as a predictor of upstaging and upgrading in prostate cancer
Prognostic value of the preoperative peripheral lymphocyte subset variations in prostate cancer
Predicting biochemical recurrence and prostate cancer specific mortality following biochemical recurrence after radical prostatectomy: Head-to-head comparison of six prediction models in a cohort of screen detected prostate cancer patients
Surgery, brachytherapy and external-beam radiotherapy for prostate cancer: What is the difference? - preliminary results
Continence outcomes of robot-assisted radical prostatectomy in patients with adverse urinary continence risk factors
Surgical techniques of the recto-urinary fistula after radical prostatectomy: Our experience
Active surveillance: Prognostic factors
Dynamic lateral suspension of posterior reconstruction suture in Robotic Radical prostatectomy: Impact on Early continence: Single centre experience in a developing country
Ten “Key Steps” in robotic radical prostatectomy: Evaluation of outcomes with respect to recovery of continence. A single surgeon-single centre experience
Is robotic radical prostatectomy feasible in men more than 75 years of age? A single institute-single surgeon experience
Changing trends in surgical management of high-risk prostate cancer over a decade in developing
Prediction of pathologically favorable disease among men undergoing radical prostatectomy for intermediate-risk prostate cancer
Contemporary management of patients with prostate cancer on biopsies in a community- based center
Increasing Time from Diagnosis to Radical Prostatectomy (RP-interval) is Not Associated with Adverse Oncological Outcomes: Implications for cancer patient pathways (CPPs)
Active Surveillance in Low-risk Prostate Cancer – a reality in real life populations?
Should residents perform Laparoscopic Radical Prostatectomy? Datebase analysis
Validation and face to face comparison of three preoperative nomograms for prediction of lymph node invasion before radical prostatectomy
Focal treatment of recurrent prostate cancer (PCa) with salvage high-dose-rate brachytherapy (HDR-BT)
Results of the efficacy Neoadjuvant chemohormonal therapy before Radical Prostatectomy for high-risk prostate cancer
A long-term, prospective, randomized-controlled trial in bladder neck sclerosis secondary to radical prostatectomy – Bipolar plasma vaporization versus monopolar TUR and “cold-knife” incision within an evidence-based critical comparison
Pro-PSA and prostate health index: aplications in diagnosis and prognosis of prostate cancer
Prostate cancer incidence related to favourable free/total PSA ratio
Does high PIRADS V2 Score on a pre biopsies Multiparametric MRI scan suggest high-Gleason score prostate cancer?
Assessment of ADC measurement using mpMRI in patients with low-risk prostate cancer (PCa) after radical prostatectomy (RP)
Learning curve and distribution of PI-RADS score in a population based series of Norwegian men examined with a mpMRI detection protocol
Where Do Micro-Ultrasound and MRI Find Prostate Cancer? A Target Localization Study
Initial Clinical Experience with 29 MHz Micro-Ultrasound for Real-Time Targeted Prostate Biopsies
Improving Standard Trans-Rectal Prostate Biopsy Results Using High Resolution Micro-Ultrasound Real-Time Targeting for Suspicious Areas
Follow-up and long-term comparison of the 8 and 12 cylinder scheme in prostate biopsy
Detection rate of mpMRI/transrectal US fusion biopsy for the diagnosis of prostate cancer in biopsy-naive patients
Multiparametric MRI to detect Prostate Cancer: Are we ready to apply it? Predictors of false-negatives in a multicentric study
Utility of mpMRI/transrectal US fusion confirmatory biopsy in men with a previous diagnosis of prostate cancer amenable to active surveillance
Diagnostic accuracy of mpMRI/transrectal US fusion biopsy in men with previous negative standard biopsy
Testicular sclerosing sertoli cell tumor: A case report and review of the literature
Retrospective comparative study between robot-assisted partial nephrectomy and open partial nephrectomy for the treatment of highly complex renal tumors with RENAL nephrometry score ≥8
The efficacy of targeted therapy after progression on Bevacizumab and Atezolizumab combination therapy in metastatic renal cell carcinoma
Evaluation of digital rectal examination compliance with fusion prostate biopsy pathology result according to the PIRADS score
Can hematological biomarkers be used to predict the results of multiparametric magnetic rezonance imaging-guided prostate biopsy? A randomized prospective study
Is serum testosterone level is not related to adenocarcinoma diagnosis of the prostate even among definitely hypogonadal patients?
Extra-transitional zone prostate specific antigen density (ETzD); A novel structure- based parameter quantifying oncological hazard of prostate from the presence of malignancy to unfavorable pathologic features
Surgical outcome of pre-operative atezolizumab before radical cystectomy for muscle-invasive urothelial carcinoma of the bladder
An unusual presentation of an external urethral mass
Variation in tumour volume of bladder cancer among histological subtypes
Comparative study between ileal conduit and Indiana pouch after cystectomy for patients with carcinoma of urinary bladder
What are the main predictors of post-operatory complications after radical cystectomy and urinary diversion?
An Analysis of Organ-Confined Muscle-Invasive Bladder Cancer Patients Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014
Results for laparoscopic radical cystectomy with ileal conduit urinary diversion: 5 years’ experience.
A comparison of squamous carcinoma of the bladder with transitional cell cancer
Quantitative proteomic analysis identifies AHNAK as a novel candidate biomarker for bladder urothelial carcinoma diagnosis
Short-term results of salvage lymphadenectomy with lymphogenous progression of prostate cancer after radical treatment
Can we rely on 18F-choline PET-CT in detection of lymphogenous metastases in prostate cancer patients with biochemical recurrence after radical treatment?
Ewing Sarcoma of the prostate – a case with rare longevity in a disease with dismal prognosis
Editorial Board

El Portal de Urología en Español para profesionales

Sumarios de Revistas

Lo último en... European Urology Supplements:

Este mes en... European Urology

El mes que viene en... Journal of Urology